You are here

Our Team

Dr. Monika Bahl, MBBS, MBA, Director Clinical Portfolio Management

Dr. Monika has joined CDSA as the Director Clinical Portfolio Management. A graduate in medicine with additional specialization in human resource management, she brings with her over 16 years of experience in clinical practice and clinical research including project planning, clinical monitoring and project management for in-house and outsourced clinical research projects. She has substantial experience of managing projects in varied therapeutic indications including immunology, pain management, cardiovascular, respiratory, dermatology, psychiatry and diabetes mellitus in previous assignments in Indian and global pharmaceutical / Biotech industry (Ranbaxy Research Laboratories, Dabur Research Foundation, Panacea Biotec, Quintiles).  

She has been associated with clinical studies in paediatric, adult and geriatric populations including mega-trials for DCGI/FDA/BfArM submissions. Her responsibilities have spanned from project planning, protocol designing, CRO selection and project management for the full duration of studies from pre-trial to project close-out, medical monitoring, data review and related medical writing. She has significantly contributed to training and mentoring programs for performance improvement and for quality management initiatives on individual, project and organizational level.

Dr. Sucheta Banerjee Kurundkar, PhD (Biochemistry), MBA, Director Training

Dr. Sucheta Banerjee Kurundkar has joined CDSA as Director Training in 2012. She has 19 years of experience in various capacities in research & CRO Industry. In her last assignment, she was Chief Scientific Officer at a multinational Clinical Research Organization. Sucheta has worked for several years in the area of Quality Assurance in pre-clinical, clinical and medical laboratories and has an avid interest in this area. She is a GLP Trainer (WHO); Auditor for NABL (ISO 15189 & ISO 17025) & NABH. Sucheta has a Ph.D. in Biochemistry from University of Pune and her doctoral work on a novel inhibitor received recognition at the World Congress on Insulin Resistance Diabetes & Cardiovascular Research, USA. She has completed Management Development Program in Advanced Quality Management from IIM, Ahmedabad and Management of Training from Institute of Secretariat Training and Management, New Delhi. She completed her MBA with specialization in Total Quality Management from SMU. Sucheta is reviewer to ten International Journals of repute. She is the recipient of CSIR International Travel Award (2010). At CDSA, she has been involved in the conduct of ~100 training programs across ~50 cities involving ~6000 participants, ~1700 institutions and ~900 faculty members.

Prashant Bhujbal, Finance Manager Bhujbal has joined CDSA as Finance Manager. He did MBA in Finance and also holds a post graduate degree in Agriculture. He has worked for more than 23 years in the Maharashtra Finance and Account Cadre under Government of Maharashtra. As a member of finance Cadre he served on diverse postings in various Government departments ranging from Account, Audit and Procurement of Goods.



Arun Kumar B. Ramteke, Consultant, Regulatory Affairs Ramteke retired as a senior drug regulatory officer with 31 years of experience in drug regulatory aspects in the office of the Drugs Controller General of India (DCGI). He has in-depth knowledge of Indian Drugs & Cosmetics Act, Rules and of regulations of Global Drug Regulatory norms. He started his career at Central Research Institute Kasauli in biological-drug testing. He has extensive experience with new drugs, vaccines and biotech products/pharmaceuticals, medical devices approvals and development experience. He also has experience in review and evaluation of product dossier for pre-clinical, toxicological, pharmacological, CMC, and quality control, clinical trial data of new drugs, biological and medical devices (INDs, ANDAs).

He has strong skills in quality assurance management, regulatory oversight of clinical trials, development of SOPs and guidelines and involvement in drug rules amendments. As an expert he has attended various national and international training workshops and meetings on drug regulations. He has contributed to preparation and implementation of Good Clinical Practices (GCP), Good Laboratory Practices (GLP) and Good Manufacturing Practices. He works as an Expert to the Pharmacovigilance Program, GCP Training and Inspections of CROs in India.